WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Stock Ownership - Who owns Lenz Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lenz Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Shawn OlssonChief Commercial Officer2025-11-175,788$26.37
$152.61kSell
Shawn OlssonChief Commercial Officer2025-11-1710,000$2.08
$20.80kBuy
Shawn OlssonChief Commercial Officer2025-11-174,212$25.74
$108.41kSell
Daniel R. ChevallardChief Financial Officer2025-11-072,178$22.76
$49.56kBuy
James W. McCollumDirector2025-11-0710,500$22.79
$239.27kBuy
Daniel R. ChevallardChief Financial Officer2025-11-0720$22.71
$454.20Buy
Versant Venture Capital VI LP10% Owner2025-09-30123$47.01
$5.78kSell
Versant Venture Capital VI LP10% Owner2025-09-3049,701$45.36
$2.25MSell
Versant Venture Capital VI LP10% Owner2025-09-3034,405$45.36
$1.56MSell
Versant Venture Capital VI LP10% Owner2025-09-3083,066$46.41
$3.85MSell

1 of 5

LENZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LENZ insiders and whales buy or sell their stock.

LENZ Shareholders

What type of owners hold Lenz Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC27.29%8,538,446$145.84MInsider
Samsara Biocapital LP27.28%8,534,820$145.77MInsider
Ra Capital Management LP13.36%4,178,823$71.37MInstitution
Alpha Wave Global LP11.54%3,612,211$61.70MInstitution
Alpha Wave Ventures GP Ltd11.54%3,612,211$61.70MInsider
Versant Venture Management LLC8.49%2,656,888$45.38MInstitution
Versant Venture Capital VI LP6.05%1,892,761$32.33MInsider
Davis Jerel5.46%1,707,719$29.17MInsider
Versant Venture Capital VII LP5.11%1,598,789$27.31MInsider
Blackrock Inc4.71%1,473,104$25.16MInstitution

1 of 3

LENZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LENZ49.80%50.20%Net SellingNet Selling
ALT39.61%60.39%Net SellingNet Selling
PRTA49.89%50.11%Net Selling
ASMB50.56%49.44%Net Buying
ANRO53.94%21.66%
View Top Biotech Stocks

Lenz Therapeutics Stock Ownership FAQ

Who owns Lenz Therapeutics?

Lenz Therapeutics (NASDAQ: LENZ) is owned by 93.13% institutional shareholders, 93.89% Lenz Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Lenz Therapeutics shareholder, owning 8.54M shares representing 27.29% of the company. Ecor1 Capital LLC's Lenz Therapeutics shares are currently valued at $142.59M.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.